New Hepatitis C Drug Linked to Stevens Johnson Syndrome
By Christina Drury
Vertex Pharmaceuticals gained approval from the FDA for their hepatitis C drug Incivek in May 2011. Designed to be used in conjunction with two other drugs, Incivek was predicted to help Vertex become profitable after nearly 22 years in business. Along with another competing drug from manufacturer Merck & Co., Incivek was hailed as a significant advancement in the treatment of hepatitis C and an improvement upon the current method of care. However, almost as immediately as it was praised, problems began to arise as the new drug was linked to a severe and potentially fatal allergic reaction known as Stevens Johnson Syndrome (SJS).
FDA Demands Black Box Warning Be Added to Incivek
Following just 18 short months on the market, the FDA ordered Vertex to add a black box warning to Incivek in December 2012. The FDA was compelled to take action after it was made aware of several reports of a serious skin rash linked to the use of Incivek. One of the more significant cases that spurred the FDA into action was that of a patient in Japan who had died from an advanced form of SJS known as Toxic Epidermal Necrolysis (TEN). The patient was unaware of the cause of the rash and continued taking Incivek, which led to the development of the more serious and life-threatening form of the skin condition.
What is Stevens Johnson Syndrome and what are the Symptoms?
Stevens Johnson Syndrome is a serious skin disease that presents itself as a rash at first. It is a severe allergic reaction to medication that the patient may have previously taken and tolerated. As the skin disease progresses, the patient develops blisters and lesions that resemble serious burns. Patients who develop SJS are often treated in the burn unit of a hospital due to its similarity to being severely burned. Other symptoms associated with SJS include:
- Facial Swelling
- Lung Damage
- Skin Pain
- Skin Rash
- Blisters on Skin and Mucous Membranes (Mouth, Nose, Eyes)
After the FDA mandated that a black box warning be added to the Incivek label, it seemed that the benefits of the already questionable medication were being outweighed by the risks. As more cases of SJS and TEN arose, lawsuits began being filed accusing drug companies of failing to adequately warn patients of the potentially life-threatening risk of developing the SJS and TEN from taking the drug.
How to Get Legal Help
If you or someone you know has taken a medication such as Incivek and have developed Stevens Johnson Syndrome or Toxic Epidermal Necrolysis, you may be eligible to receive compensation. To learn more about the current litigation involving SJS and TEN drugs, please visit our Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation web page. Once you submit your information to our team of compensation specialists, you will receive free advice on your individual circumstances and how you can proceed with your lawsuit if you have a case.
Updated March 21st, 2013
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement